Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective

Prednisolone, used as a standard initial treatment for immune thrombocytopenia (ITP), is an important risk factor for osteoporosis. Recently, we found that prescription of bisphosphonate during initial loading of prednisolone may prevent reduction in bone mineral density and development of glucocort...

Descripción completa

Detalles Bibliográficos
Autor principal: Yamasaki, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175903/
https://www.ncbi.nlm.nih.gov/pubmed/37171596
http://dx.doi.org/10.1007/s00277-023-05266-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175903/
https://www.ncbi.nlm.nih.gov/pubmed/37171596
http://dx.doi.org/10.1007/s00277-023-05266-7

Ejemplares similares